The role of medical treatment in chronic subdural hematoma

Surgery is the standard treatment for chronic subdural hematoma (CSDH), one of the common problems in neurosurgical practice. Although medical treatment was used by some authors and found some positive results, it is not accepted by many authors. The aim of this review is to give overall view of the...

Full description

Saved in:
Bibliographic Details
Published in:Asian journal of neurosurgery 2018-10, Vol.13 (4), p.976-983
Main Authors: Thotakura, Amit, Marabathina, Nageswara
Format: Article
Language:English
Subjects:
Care and treatment
Review
Review Article
Subdural hematoma
Therapeutics
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Surgery is the standard treatment for chronic subdural hematoma (CSDH), one of the common problems in neurosurgical practice. Although medical treatment was used by some authors and found some positive results, it is not accepted by many authors. The aim of this review is to give overall view of the medical management of CSDH. Action of various drugs in the pathophysiological cascade of formation of CSDH was depicted. The review of literature is done under three headings – the primary medical treatment of CSDH, adjuvant medical treatment with surgery, and the treatment of the recurrence. Various classifications of CSDH and the factors influencing the outcome of medical treatment are discussed. There is a role of medical treatment in a selected group of patients with CSDH. Well-designed, multicenter, randomized controlled trials are required to define the indications and standard protocols for the medical treatment of CSDH.
ISSN:1793-5482
2248-9614
DOI:10.4103/ajns.AJNS_13_17